Perspective Therapeutics Inc (CATX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Sales | 342 | 234 | 369 | 526 | 325 |
| Gross Profit | 342 | 234 | 369 | 526 | 325 |
| Operating Expenses | 22,174 | 45,218 | 19,003 | 14,789 | 13,330 |
| Operating Income | -21,832 | -44,984 | -18,634 | -14,263 | -13,005 |
| Interest Expense | 128 | -73 | 69 | 23 | 29 |
| Other Income | 3,783 | 2,645 | 3,581 | 3,072 | 1,209 |
| Pre-tax Income | -18,177 | -42,266 | -15,122 | -11,214 | -11,825 |
| Net Income Continuous | -18,177 | -42,266 | -15,122 | -11,214 | -11,825 |
| Net Income Discontinuous | N/A | N/A | N/A | -490 | -459 |
| Net Income | $-18,177 | $-40,169 | $-15,122 | $-11,704 | $-12,284 |
| EPS Basic Total Ops | -0.25 | -0.59 | -0.21 | -0.18 | -0.25 |
| EPS Basic Continuous Ops | -0.25 | -0.60 | -0.21 | -0.17 | -0.24 |
| EPS Basic Discontinuous Ops | N/A | 0.01 | N/A | -0.01 | -0.01 |
| EPS Diluted Total Ops | -0.25 | -0.59 | -0.21 | -0.18 | -0.25 |
| EPS Diluted Continuous Ops | -0.25 | -0.60 | -0.21 | -0.17 | -0.24 |
| EPS Diluted Discontinuous Ops | N/A | 0.01 | N/A | -0.01 | -0.01 |
| EPS Diluted Before Non-Recurring Items | -0.25 | N/A | -0.21 | -0.17 | N/A |
| EBITDA(a) | $-22,090 | $-20,820 | $-17,965 | $-13,691 | $-12,649 |